SEC Company Response from Zentalis Pharmaceuticals, Inc. (ZNTL) (CIK 0001725160) (ZNTL) — Mar 31, 2020
Zentalis Pharmaceuticals, Inc. (ZNTL) (CIK 0001725160)
Date: March 31, 2020 · CIK: 0001725160 · Accession: 0001193125-20-092900
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236959
Letter
Re:
March 31, 2020
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4720
Washington, D.C. 20549
Attention:
Chris Edwards
Zentalis Pharmaceuticals, LLC
Registration Statement on Form S-1 (File No. 333-236959)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 1,344 copies of the Preliminary Prospectus dated March 30, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, April 2, 2020 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 31, 2020 United States Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4720 Washington, D.C. 20549 Attention: Chris Edwards Re: Zentalis Pharmaceuticals, LLC Registration Statement on Form S-1 (File No. 333-236959) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that as of the date hereof, approximately 1,344 copies of the Preliminary Prospectus dated March 30, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, April 2, 2020 or as soon thereafter as practicable. [Signature page follows] Very truly yours, MORGAN STANLEY & CO. LLC JEFFERIES LLC SVB LEERINK LLC As representatives of the Underwriters MORGAN STANLEY & CO. LLC By: /s/ Kalli Dirks Name: Kalli Dirks Title: Executive Director JEFFERIES LLC By: /s/ Michael Brinkman Name: Michael Brinkman Title: Managing Director SVB LEERINK LLC By: /s/ Gabriel Cavazos Name: Gabriel Cavazos Title: Managing Director [Signature Page to Acceleration Request]